AU2003249999A8 - 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours - Google Patents
1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumoursInfo
- Publication number
- AU2003249999A8 AU2003249999A8 AU2003249999A AU2003249999A AU2003249999A8 AU 2003249999 A8 AU2003249999 A8 AU 2003249999A8 AU 2003249999 A AU2003249999 A AU 2003249999A AU 2003249999 A AU2003249999 A AU 2003249999A AU 2003249999 A8 AU2003249999 A8 AU 2003249999A8
- Authority
- AU
- Australia
- Prior art keywords
- tetraazacyclododecanes
- guanine
- modulators
- binding protein
- treating tumours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10231270 | 2002-07-10 | ||
| DE10231270.2 | 2002-07-10 | ||
| DE10239612A DE10239612A1 (en) | 2002-07-10 | 2002-08-29 | Methods and connections for influencing the spatial structure of GNB proteins |
| DE10239612.4 | 2002-08-29 | ||
| PCT/EP2003/007367 WO2004006934A2 (en) | 2002-07-10 | 2003-07-09 | 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003249999A8 true AU2003249999A8 (en) | 2004-02-02 |
| AU2003249999A1 AU2003249999A1 (en) | 2004-02-02 |
Family
ID=30116624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003249999A Abandoned AU2003249999A1 (en) | 2002-07-10 | 2003-07-09 | 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003249999A1 (en) |
| WO (1) | WO2004006934A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101106433B1 (en) * | 2009-04-03 | 2012-01-18 | 서울대학교산학협력단 | Macrocyclic Amino Acid Derivatives and Radioactive or Nonradioactive Metal Labeling Compounds for Targeting Cancer Tissues |
| EP2671575A1 (en) | 2012-06-04 | 2013-12-11 | Universität Regensburg | Ras inhibitors |
| WO2014153624A1 (en) * | 2013-03-28 | 2014-10-02 | The University Of Sydney | Antibacterial compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3640708C2 (en) * | 1986-11-28 | 1995-05-18 | Schering Ag | Improved pharmaceuticals containing metals |
| DE4009119A1 (en) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
| US5272056A (en) * | 1991-01-03 | 1993-12-21 | The Research Foundation Of State University Of New York | Modification of DNA and oligonucleotides using metal complexes of polyaza ligands |
| DE19603033A1 (en) * | 1996-01-19 | 1997-07-24 | Schering Ag | Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics |
| DE19608278A1 (en) * | 1996-02-23 | 1997-08-28 | Schering Ag | Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology |
| DE19641197C2 (en) * | 1996-09-24 | 1999-02-18 | Schering Ag | Ion pairs and their use as contrast agents |
| DE19719033C1 (en) * | 1997-04-29 | 1999-01-28 | Schering Ag | Ion pairs, processes for their preparation and their use as contrast agents |
| AU6074599A (en) * | 1998-10-13 | 2000-05-01 | Synchem Reserach, Inc. | Biomimetic chelating agents and methods |
| DE19849465A1 (en) * | 1998-10-21 | 2000-04-27 | Schering Ag | New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents |
| US6667320B2 (en) * | 1999-12-17 | 2003-12-23 | Anormed | Chemokine receptor binding heterocyclic compounds |
| AU2001244609A1 (en) * | 2000-03-30 | 2001-10-15 | Takeda Chemical Industries Ltd. | Novel protein, dna thereof and process for producing the same |
| AU2001286644A1 (en) * | 2000-08-25 | 2002-03-13 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the gng7 gene |
| DE10104389A1 (en) * | 2001-01-19 | 2002-08-01 | Schering Ag | New multimeric photosensitizer, useful in photodynamic therapy of cancers and other angiogenic conditions, can also be conjugated with e.g. protein, antibody or oligonucleotide |
-
2003
- 2003-07-09 WO PCT/EP2003/007367 patent/WO2004006934A2/en not_active Application Discontinuation
- 2003-07-09 AU AU2003249999A patent/AU2003249999A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004006934A2 (en) | 2004-01-22 |
| WO2004006934A3 (en) | 2004-04-01 |
| AU2003249999A1 (en) | 2004-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164533A0 (en) | Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds | |
| AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
| HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
| PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
| GB0512560D0 (en) | Bioreactors for well treatment | |
| AP2210A (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain. | |
| ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
| AU2003218767A1 (en) | Fabric treatment composition | |
| IL169633A0 (en) | Combination therapy for treating protein deficiencies | |
| ZA200408767B (en) | Immunoconjugates for the treatment of tumours | |
| EP1572118A4 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
| EP1442062A4 (en) | Methods for the treatment of carcinoma | |
| AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
| PL377464A1 (en) | Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| EP1551388A4 (en) | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | |
| MXPA03007314A (en) | Improved skin composition. | |
| AP2004003070A0 (en) | The method of treating cancer. | |
| IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
| ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
| AU2003223538A1 (en) | Methods for the treatment of cancer | |
| LT1496918T (en) | Use of sodium meta-arsenite for the treatment of tumours | |
| AU2003249999A8 (en) | 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours | |
| AU2003296545A1 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
| AU2003232108A8 (en) | 1,1- and 1,2-bisphosphonates as apoliprotein e modulators | |
| AU2002304883A1 (en) | Device for the treatment of tumours |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |